Skip to main content

Detect Impairment with Real-Time Measurements

Make better informed cardiorespiratory decisions to improve patient outcomes

agm100 black background-web

Enhanced Decision Making

Experience enhanced decision-making capabilities with the AGM100 with instant access to crucial information on a patient's oxygenation, ventilatory status, and gas exchange impairment. This cutting-edge device empowers you to make the most informed clinical decisions possible.

Revolutionizing the way we comprehend oxygenation and respiratory impairment, the AGM100 provides multiple, real-time measurements to improve patient care.


Use AGM100 to detect impairment

Identify the degree of respiratory impairment to improve clinical decision making

Pulmonary Gas Exchange

Pulmonary gas exchange in the alveoli is a vital process where blood exchanges carbon dioxide for oxygen. In the lungs, tiny air sacs called alveoli are surrounded by small blood vessels or capillaries. Oxygen-depleted blood, carrying carbon dioxide from the body, flows into these capillaries. Here, oxygen from the air in the alveoli moves into the blood, while carbon dioxide from the blood is released into the alveoli. This exchange happens through diffusion, where gases naturally move from an area of higher concentration to lower concentration. The refreshed, oxygen-rich blood then travels back to the heart to be circulated throughout the body, and carbon dioxide is exhaled from the lungs.

This process is essential for maintaining the balance of oxygen and carbon dioxide in our bodies. Our technology detects the levels of these gases (known as PO2 or PCO2) to detect abnormalities to help medical staff better assess patient’s impairment and overall cardiorespiratory health.

    Normal Gas Exchange

All parameters - green (low O2 deficit)

  Abnormal Gas Exchange

all parameters - red (high O2 deficit)
During steady-state breathing, a patient with no gas exchange impairment should exhibit a low O2 deficit between 0-15 mmHg, which signifies little to no impairment between the lung’s alveolar oxygen levels and the arterial blood oxygen levels. In addition, normal CO2 levels indicate adequte ventilation and normal arterial blood oxygen indicate adequte oxygenation.
Patients with moderate to severe respiratory impairment will display an elevated O2 deficit, with other parameters on screen used to narrow differential diagnosis and identify the source of hypoxemia. Values on the right hand side of the screen also shows issues with oxygen moving from alveoli (PAO2 of 118) to blood (PaO2 of 57), which indicates gas exchange impairment.

AGM® Measurements

Symbol Description
gPaO2 Calculated arterial partial pressure of oxygen, mmHg
PETCO2 End-tidal carbon dioxide partial pressure, mmHg
Oxygen Deficit Gas exchange inefficiency (PAO2-gPaO2), mmHg
SpO2 Blood oxygen saturation, %
Respiratory Rate (RR) The number of breaths per minute
Pulse Rate (PR)
The number of heart beats per minute
PAO2 End-tidal oxygen partial pressure, mmHg
gPaO2/ FiO2 Ratio of arterial partial pressure of oxygen to fraction of oxygen inspired
gPaO2/ PAO2 Arterial to alveolar partial pressure of oxygen exchange ratio
RQ Respiratory quotient, ratio of carbon dioxide produced to oxygen used
PiO2 Partial pressure of inspired oxygen, mmHg
Pbar Barometric pressure, mmHg


Latest Articles from our Blog

Get the latest news on MediPines as we continue to advance respiratory medicine.

MediPines Announces New Reimbursement Code for Non-Invasive Assessment of Cardiorespiratory Status by the AGM100

New AMA CPT® Code Establishes Pathway For Clinicians To Submit Claims For Use Of MediPines AGM100®

MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies

MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the "Make Your Medical Device Pitch for Kids!" competition presented by ...

UCSD Distinguished Lecture Series

UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines, to Feature Nobel Laureate Dr. Gregg L. Semenza August 02, 2023 11:57 AM Eastern Daylight Time MediPines, ...

Medscape Interview Highlights MediPines AGM100’s 99% Accuracy for Emergency Room Oxygen Therapy Decisions in COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a video interview on “Hot Topics in Emergency Medicine” posted by Medscape, a group of emergency medicine experts and respiratory physiology ...

Medipines Featured in Los Angeles Business Journal

Innovative Technology Detects Respiratory Impairment Respiratory impairment detection has long been a diagnostic “blind spot,” with the traditional tools available causing ...

Emergency Department Study Demonstrates Utility of MediPines AGM100 in Triaging COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a study presented at the American Thoracic Society (ATS) International Conference 2022, the MediPines AGM100 was shown to provide data that ...

Physicians Use MediPines Non-Invasive Gas-Exchange Analyzer Technology to Assist with Differential Diagnosis for Pulmonary Embolism

YORBA LINDA, Calif., May 24, 2022–(BUSINESS WIRE)–An increasing number of physicians have been utilizing a unique gas exchange analyzer technology to enhance recognition and ...

MediPines Adds Three Global Thought Leaders to its Medical and Scientific Advisory Board

March 01, 2022 12:04 PM Eastern Standard Time YORBA LINDA, Calif.–(BUSINESS WIRE)–Orange County, California based MediPines Corporation, a market leader in the development of gas ...

World Health Organization Recognizes MediPines AGM100® in 2021 Compendium for Innovative Health Technologies

ORANGE COUNTY, Calif., Sept. 21, 2021 /CNW/ — The World Health Organization (WHO) has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology ...

MediPines AGM100® – Medical Design Excellence 2021 Award Winner

MediPines is pleased to announce that their AGM100® device has been awarded the prestigious Silver Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence ...

MediPines AGM100® Gas Exchange Measurements Validated Against ABGs (Arterial Blood Gases)

Study Published in CHEST Validates MediPines AGM100® Non-invasive Pulmonary Gas Exchange Measurements with Arterial Blood Gases Under Hypoxic Conditions ORANGE COUNTY, Calif., May ...

MediPines Obtains International MDSAP ISO 13485 Medical Device Certification

ORANGE COUNTY, Calif., April 9, 2020 /PRNewswire/ — MediPines Corporation announces that it received the Medical Device Single Audit Program certification, MDSAP ISO 13485:2016 ...

FDA Cleared MediPines Gas Exchange Monitor Measures Freedivers’ Lung Efficiency in Ground-Breaking Study

Successful Study Findings Unveiled by University of British Columbia Researchers at International Conference in Orlando, Florida PR Newswire ORANGE COUNTY, Calif., April 12, 2019 ...

MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor

ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the ...